Keith Crandell
Affiliations
- at 908 Devices Inc. (MASS), 2024-06-14
- at Rapport Therapeutics Inc. (RAPP), 2024-06-10
- at Boundless Bio Inc. (BOLD), 2024-04-04
- Large Shareholder at Prime Medicine Inc. (PRME), 2024-02-20
- Large Shareholder at Sana Biotechnology Inc. (SANA), 2024-02-12
- at Twist Bioscience Corp (TWST), 2024-02-09
- Large Shareholder at Neumora Therapeutics Inc. (NMRA), 2023-12-13
- Large Shareholder, Director at Da32 Life Science Tech Acquisition Corp. (DALS), 2023-08-11
- at Quanterix Corp (QTRX), 2023-04-04
- Large Shareholder at Codiak Biosciences Inc. (CDAK), 2022-09-15
- Large Shareholder at Vir Biotechnology Inc. (VIR), 2022-09-08
- Large Shareholder at Erasca Inc. (ERAS), 2021-07-21
- Large Shareholder at Beam Therapeutics Inc. (BEAM), 2021-06-29
- Large Shareholder at Lyell Immunopharma Inc. (LYEL), 2021-06-23
- Large Shareholder at Verve Therapeutics Inc. (VERV), 2021-06-23
- Large Shareholder at Karuna Therapeutics Inc. (KRTX), 2021-04-15
- Large Shareholder at Metacrine Inc. (MTCR), 2020-09-22
- Large Shareholder at Denali Therapeutics Inc. (DNI), 2019-08-13
- Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2019-07-17
- Director at Adesto Technologies Corp (IOTS), 2019-06-06
- Large Shareholder at Homology Medicines Inc. (FIXX), 2019-05-23
- Large Shareholder at Sienna Biopharmaceuticals Inc. (SNNA), 2019-02-27
- Large Shareholder at Gossamer Bio Inc. (GOSS), 2019-02-12
- Large Shareholder at Scholar Rock Holding Corp (SRRK), 2018-06-01
- Large Shareholder at Unity Biotechnology Inc. (UBX), 2018-05-07
- Other at Pulmatrix Inc. (PULM), 2018-04-12
- Large Shareholder at Xtera Communications Inc. (XCOM), 2016-10-13
- Large Shareholder at Impinj Inc (PI), 2016-08-31
- Large Shareholder at Phaserx Inc. (PZRX), 2016-05-25
- Large Shareholder at Juno Therapeutics Inc. (JUNO), 2016-03-18
- Large Shareholder at Juno Lighting Inc (JUNO), 2016-03-18
- Large Shareholder at Vbi Vaccines Inc. (VBIV), 2015-08-17
- Large Shareholder at Sage Therapeutics Inc. (SAGE), 2015-06-22
- Large Shareholder at Bellerophon Therapeutics Inc. (BLPH), 2015-02-24
- Large Shareholder at Agios Pharmaceuticals Inc (AGIO), 2015-02-23
- Large Shareholder at Receptos Inc. (RCPT), 2014-05-15
- Large Shareholder at Achaogen Inc (AKAO), 2014-03-17
- Large Shareholder at Fate Therapeutics Inc (FATE), 2013-10-07
- Large Shareholder at Bluebird Bio Inc. (BLUE), 2013-06-26
- Large Shareholder at Kythera Biopharmaceuticals Inc (KYTH), 2012-10-16
- Large Shareholder at Neurogesx Inc (NGSX), 2011-07-26
- Large Shareholder at Trubion Pharmaceuticals Inc (TRBN), 2010-11-01
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
BOLD | $16.00 | 133,333 | 1,181,766 | 2024-04-02 | Filing | ||
BOLD | $16.00 | 66,667 | 683,759 | 2024-04-02 | Filing | ||
SANA | $5.50 | 727,272 | Large Shareholder | 12,446,022 | 2024-02-08 | Filing | |
SANA | $5.50 | 727,272 | Large Shareholder | 12,446,022 | 2024-02-08 | Filing | |
SANA | $5.50 | 363,637 | Large Shareholder | 10,667,387 | 2024-02-08 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
TWST | $107.56 | 2,555 | Director | 76,047 | 2021-08-12 | Filing | |
TWST | $106.98 | 41,033 | Director | 78,602 | 2021-08-12 | Filing | |
TWST | $106.93 | 1,412 | Director | 486 | 2021-08-12 | Filing | |
TWST | $103.40 | 21,288 | 288,104 | 2020-12-07 | Filing | ||
TWST | $103.40 | 53,712 | 726,834 | 2020-12-07 | Filing |